Abstract:Ubiquitin-specific protease 14 (USP14), a deubiquitinating enzyme (DUB), is associated with proteasomes and exerts a dual function in regulating protein degradation. USP14 protects protein substrates from degradation by removing ubiquitin chains from proteasome-bound substrates, whereas promotes protein degradation by activating the proteasome. Increasing evidence have shown that USP14 is involved in several canonical signaling pathways, correlating with cancer, neurodegenerative diseases, autophagy, immune responses, and viral infections. The activity of USP14 is tightly regulated to ensure its function in various cellular processes. Structural studies have demonstrated that free USP14 exists in an autoinhibited state with two surface loops, BL1 and BL2, partially hovering above and blocking the active site cleft binding to the C-terminus of ubiquitin. Hence, both proteasome-bound and phosphorylated forms of USP14 require the induction of conformational changes in the BL2 loop to activate its deubiquitinating function. Due to its intriguing roles in the stabilization of disease-causing proteins and oncology targets, USP14 has garnered widespread interest as a therapeutic target. In recent years, significant progress has been made on identifying inhibitors targeting USP14, despite the complexity and challenges in improving their selectivity and affinity for USP14. In particular, the crystal structures of USP14 complexed with IU1-series inhibitors revealed the underlying allosteric regulatory mechanism and enabled the further design of potent inhibitors. In this review, we summarize the current knowledge regarding the structure, regulation, pathophysiological function, and selective inhibition of USP14, including disease associations and inhibitor development.

Spotlight on USP4: Structure, Function, and Regulation

Ubiquitin-specific peptidase 22 in cancer

USP14: Structure, Function, and Target Inhibition

Structure and Function of USP5: Insight into Physiological and Pathophysiological Roles.

Insights Into the Properties, Biological Functions, and Regulation of USP21

USP5: Comprehensive insights into structure, function, biological and disease-related implications, and emerging therapeutic opportunities

Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors

USP15 in Cancer and Other Diseases: From Diverse Functionsto Therapeutic Targets

Structure and Function of the Highly Homologous Deubiquitinases Ubiquitin Specific Peptidase 25 and 28: Insights into Their Pathophysiological and Therapeutic Roles.

USP3: Key deubiquitylation enzyme in human diseases

The Dual Role of USP11 in Cancer

USP30: Structure, Emerging Physiological Role, and Target Inhibition

Structure and Mechanisms of the Proteasome-Associated Deubiquitinating Enzyme USP14.

Ubiquitin specific peptidase 3: an emerging deubiquitinase that regulates physiology and diseases

Recent Insights into USP7: Construct, Pathophysiology, and Inhibitors

USP13: Multiple Functions and Target Inhibition

USP10 as a Potential Therapeutic Target in Human Cancers

USP7: Target Validation and Drug Discovery for Cancer Therapy

Targeting Ubiquitin Specific Protease 7 in Cancer: A Deubiquitinase with Great Prospects

Ubiquitin-specific Protease 20 in Human Disease: Emerging Role and Therapeutic Implications

Structure, Inhibitors, and Biological Function in Nervous System and Cancer of Ubiquitin-Specific Protease 46